National Health (Pharmaceutical Benefits Therapeutic Groups) Amendment Determination 2013 (No. 3) (PB No. 47 2013) (Cth)

PB 47 of 2013

National Health (Pharmaceutical Benefits – Therapeutic Groups) Amendment Determination 2013 (No. 3)

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this determination under subsection 84AG(1) of the National Health Act 1953.

Dated         26  July 2013

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health and Ageing

1. Name of Determination

(1)     This Determination is the National Health (Pharmaceutical Benefits – Therapeutic Groups) Amendment Determination 2013 (No. 3).

(2)     This Determination may also be cited as PB 47 of 2013.

1. Commencement

This Determination commences on 1 August 2013.

3              Amendments to PB 1 of 2010

Schedule 1 amends the National Health (Pharmaceutical Benefits – Therapeutic Groups) Determination 2010 (PB 1 of 2010).

Schedule 1             Amendments

[1]      Section 4 Definitions

omit:

ACE inhibitor group means the Angiotensin converting enzyme inhibitor group.

[2]      Omit entry for Schedule 1, Part 1